New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 14, 2012
11:27 EDTANF, ANFAbercrombie & Fitch upgraded to Buy from Outperform at CLSA
Price target raised to $52 from $39.
News For ANF From The Last 14 Days
Check below for free stories on ANF the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent ANF news | >>
August 28, 2014
12:34 EDTANFOn The Fly: Midday Wrap
Stocks on Wall Street were lower at midday as concern over the Ukraine crisis overshadowed an upward revision to the government's estimate of U.S. economic growth in the second quarter. The major averages began the session in negative territory and picked up downside momentum in early trading, but soon after began to drift off their lows and recapture some of their losses. Volume remains light, as is expected ahead of the upcoming long weekend. ECONOMIC EVENTS: In the U.S., Q2 GDP growth was unexpectedly boosted to 4.2% from the first estimate of 4.0%. Personal consumption rose 2.5% during the second quarter, versus estimates for a 2.4% increase. Initial jobless claims ticked down slightly to 298K in the fourth week of August. Pending home sales index increased 3.3% in July, which was better than the 0.5% month-over-month increase that was expected. In Europe, Ukraine president Poroshenko reportedly accused Russia of a "de facto" invasion and canceled a trip to call an urgent meeting of his security and defense council. COMPANY NEWS: Shares of Visa (V) declined 1% after Raymond James lowered its rating on the credit card giant's stock to Market Perform from Outperform. The Dow component faces a number of headwinds, including tougher negotiating tactics by larger international banks looking to win better deals, lower cross-border volume, and loss of processing revenue in Russia, wrote Raymond James analyst Wayne Johnson. MAJOR MOVERS: Among the notable gainers was Repros Therapeutics (RPRX), which jumped 20% after the first of two identical pivotal studies comparing Androxal to an FDA approved topical gel and placebo achieved superiority in both co-primary endpoints and Piper Jaffray hiked its price target on the stock to $33 from $26. Also higher was Signet Jewelers (SIG), which rose nearly 7% after reporting Q2 results that analysts at Sterne Agee called "impressive." Among the noteworthy losers were a number of retailers who dropped after reporting results from their most recent fiscal quarters. Shares of home goods retailer William-Sonoma (WSM) dropped 11%, jeans maker Guess (GES) fell 9%, and apparel retailer Abercrombie & Fitch (ANF) slipped more than 4%. INDEXES: Near midday, the Dow was down 33.92, or 0.2%, to 17,088.09, the Nasdaq was down 4.52, or 0.1%, to 4,565.11, and the S&P 500 was down 2.04, or 0.1%, to 1,998.08.
12:24 EDTANFAbercrombie & Fitch shares defended at Jefferies
Subscribe for More Information
12:03 EDTANFGuess hits 52-week low as Q2 results miss estimates, FY15 outlook lowered
Subscribe for More Information
10:34 EDTANFAbercrombie drops as Q2 sales fall below analysts' estimates
Subscribe for More Information
09:41 EDTANFAbercrombie & Fitch shares defended at Oppenheimer
Subscribe for More Information
09:10 EDTANFAbercrombie & Fitch sees margins in 2H14 to improve vs. 1H14
Subscribe for More Information
08:55 EDTANFOn The Fly: Pre-market Movers
HIGHER: Digital Ally (DGLY), up 16% after announcing order from Michigan State Police for over $1.1M... EnteroMedics (ETRM), up 12.4% after reporting three-year data from Maestro RC system... Repros (RPRX), up 0.8% after Androxal achieves superiority in both co-primary endpoints in a study... Synthetic Biologics (SYN), up 2.7% after Pfizer (PFE) was granted FDA Fast Track designation for its investigational Clostridium difficile vaccine candidate. Synthetic Biologics announced earlier this week that SYN-004, the company's lead anti-infective product candidate for the prevention of the effects of C. difficile, will be presented in October... Signet (SIG), up 3.9% after Q2 revenue tops consensus. DOWN AFTER EARNINGS: Abercrombie & Fitch (ANF), down 5.7%... Guess (GES), down 8.3%... Frontline (FRO), down 7%. ALSO LOWER: Williams-Sonoma (WSM), down 10.9% after downgraded at Morgan Stanley following the company's Q2 earnings report... GT Advanced (GTAT), down 2% after downgraded at Raymond James... Sungy Mobile (GOMO), down 20.1% following earnings report, CFO resignation, downgrade of stock at Oppenheimer... Genesco (GCO), down 7.7% after cutting fiscal year forecast.
08:52 EDTANFAbercrombie continues to expect 'another strong year' of growth in FY14
Subscribe for More Information
08:42 EDTANFAbercrombie says continuing to operate in 'challenging' U.S. enviornment
Subscribe for More Information
08:14 EDTANFAbercrombie & Fitch sees FY14 tax rate in mid-30s
Sees weighted average share count of approximately 73.6M shares in FY14. Comments taken from slides found in company's Q2 earnings conference call presentation
07:43 EDTANFAbercrombie & Fitch CEO says Q2 sales were 'somewhat below plan'
Subscribe for More Information
07:38 EDTANFAbercrombie & Fitch backs FY14 EPS view of $2.15-$2.35, consensus $2.36
Subscribe for More Information
07:35 EDTANFAbercrombie & Fitch reports Q2 EPS ex-items 19c, consensus 11c
Subscribe for More Information
August 27, 2014
15:27 EDTANFNotable companies reporting before tomorrow's open
Subscribe for More Information
15:19 EDTANFAbercrombie & Fitch technical commentary ahead of earnings
Subscribe for More Information
13:22 EDTANFAbercrombie & Fitch August weekly 45 straddle priced for 7.1% move into Q2
Subscribe for More Information
12:51 EDTANFEarnings Preview: Abercrombie guides FY15 EPS $2.15-$2.35
Subscribe for More Information
August 25, 2014
13:44 EDTANFAbercrombie & Fitch weekly volatility elevated into Q2 and outlook
Abercrombie & Fitch August weekly call option implied volatility is at 96, September is at 48, October is at 44, December is at 38; compared to its 26-week average of 45 according to Track Data, suggesting large near term price movement into the expected release of Q2 results on August 26.
August 22, 2014
12:08 EDTANFGap hits 52-week high following beat and raise quarter
Shares of specialty apparel retailer The Gap (GPS) are advancing after the company posted better than expected second quarter results, and raised its fiscal 2014 profit outlook. WHAT'S NEW: Last night, Gap reported Q2 earnings per share of 75c and revenue of $3.98B, topping analysts’ consensus estimates of 69c and $3.96B, respectively. Q2 same store sales were flat versus the prior year period. WHAT’S NOTABLE: For FY14, Gap raised its EPS view to $2.95-$3.00 from $2.90-$2.95, versus consensus of $2.95. The company updated its guidance for FY14 diluted EPS to reflect the 5c related to the gain on asset sale. For FY14, the company continues to expect capital spending to be approximately $750M in support of its outlined strategies. Gap also announced it will enter India through franchise-operated Gap brand stores in 2015. Gap is partnering with Arvind Lifestyle Brand Limited, a subsidiary of Arvind Limited, which is one of India’s largest textile companies. The first stores are expected to open in India’s two largest cities – Mumbai and Delhi – starting with Gap’s Summer 2015 collection for adults, kids and babies. The brand plans to open about 40 franchise-operated Gap stores in India. ANALYST REACTION: This morning, analyst commentary was decidedly positive. Research firm Janney Capital upgraded Gap to Buy from Neutral. The firm upgraded shares based on the overall improving Softlines sector due to an inventory correction, Old Navy strength, global opportunities, potential improved gross margin returns on inventory investment, and best-in-class management. Their price target on the shares is $51. Another firm, UBS, said Gap is well positioned for second half upside citing its Omni-channel advantage, shift to higher margin businesses, increased square footage, and modestly positive comps driven by ecommerce. UBS has a Buy rating and a $50 price target on the stock. Sterne Agee says Gap’s valuation is very attractive. The firm believes that Gap's fundamentals are improving, while the setup for the stock over the next 12-18 months is favorable. It adds that the company's gross margins should be boosted by several factors going forward, and it kept a Buy rating on the shares. PRICE ACTION: In late morning trading, Gap rose $2.04, or 4.7%, to $45.22 on heavy trading volume. Earlier in the session, it reached a new 52-week high of $45.47. Including today’s advance, the stock has gained over 7.5% over the past twelve months. OTHERS TO WATCH: Other specialty apparel companies include Abercrombie & Fitch (ANF), American Eagle Outfitters (AEO), Guess (GES), and The Buckle (BKE).
August 19, 2014
11:53 EDTANFAeropostale soars as Geiger returns as CEO
Subscribe for More Information
1 | 2 | all recent ANF news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use